Skip to content
Clinical Trials – home

Unidade Local De Saúde De Santa Maria, E.P.E.

Verifiedinfo

Portugal Avenida Professor Egas Moniz, 1649-035 Lisbon, Portugal

  • 136 trials recruiting
  • Non-small cell lung cancer · Breast cancer · Pulmonary arterial hypertension
  • Adults and children

About Specializations

Unidade Local De Saúde De Santa Maria, E.P.E. in Lisbon, Portugal specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Pulmonary arterial hypertension, Sjogren's syndrome, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases Research

At Unidade Local De Saúde De Santa Maria, E.P.E., the Pediatria department is involved in clinical research focused on Nutritional and Metabolic Diseases, with a strong emphasis on rare inherited conditions affecting metabolism.

  • Studies centered on Arginase 1 deficiency (ARG1-D), a rare metabolic disorder that can disrupt the body’s ability to process arginine.
  • Research evaluating a new therapy for young children, with attention to how treatment may influence plasma arginine concentrations.
  • Pediatric trials designed to better understand treatment safety and potential clinical benefit in very early childhood.

This area of research at the Lisbon site supports efforts to improve care for children with rare metabolic diseases by testing whether emerging treatments can help manage the underlying biochemical imbalance.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avenida Professor Egas Moniz1649-035 LisbonPortugal
Recruiting now
136 trials
Conditions studied
197
Partner status
Verified

More sites in LisbonPortugal

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

326 clinical trials

Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:PortugalPortugal
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Renal disorder

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:NAVENIBART
  • Sponsor:Astria Therapeutics Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.